医薬品添加剤の世界市場レポート 2025年

医薬品添加剤市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9%で、14兆2,630億2,000万米ドルに成長します。予測期間の成長は、政府のイニシアティブ、新薬の市場開拓の増加、医療支出の増加、高齢者の急速な増加が市場成長の原動力になると考えられます。予測期間における主要動向としては、プラスチックの使用量を削減するためのサステイナブル包装への注力、市場での地位を強化するためのM&Aへの注力、温室効果ガス排出量の削減への注力、人工知能を活用した栄養素や水量の追跡、サプライチェーンの透明性向上などが挙げられます。

ジェネリック医薬品販売の世界の増加は、医薬品添加剤市場の拡大に極めて重要な役割を果たしています。ジェネリック医薬品はブランド医薬品の代替品として、同じ剤形、安全性、強さ、投与経路、品質を維持しています。India Brand Equity Foundation（IBEF）が指摘するように、インドはジェネリック医薬品の世界最大の貢献国であり、ジェネリック医薬品はこのカテゴリーの世界総輸出額の20％を占めています。特筆すべきは、インドの製薬会社が米国でジェネリック医薬品の承認を300件取得したことで、ジェネリック医薬品の需要増加により医薬品添加剤市場がさらに活性化していることです。

生物製剤の販売増加は、今後数年間の医薬品無菌検査市場の成長を促進すると予想されます。生物製剤（生物学的製品）とは、生物由来の医薬品を指し、ワクチン、血液と血液成分、アレルゲン、体細胞、遺伝子治療、組織、組換え治療用タンパク質など、さまざまな製品が含まれます。医薬品添加剤は、安定性を高め、製剤化を改善し、活性な生物学的薬剤の最適な送達を確保するために生物製剤に採用されています。例えば、2022年5月に発行されたEuropean Pharmaceutical Reviewのレポートによると、生物製剤の売上高は今後5年間で革新的な低分子の売上高を大幅に上回り、2027年までにさらに1,200億米ドルの売上高を生み出すと予測されています。その結果、生物製剤の売上高は医薬品添加剤市場の成長に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品添加剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品添加剤市場：成長率分析
• 世界の医薬品添加剤市場の実績：規模と成長、2019～2024年
• 世界の医薬品添加剤市場の予測：規模と成長、2024～2029年、2034年
• 世界の医薬品添加剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品添加剤市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 無機化学品
• 有機化学品
• その他
• 世界の医薬品添加剤市場：機能別、実績と予測、2019～2024年、2024～2029年、2034年
• 充填剤と希釈剤
• 懸濁剤と粘性剤
• コーティング剤
• 結合剤
• 香料と甘味料
• 崩壊剤
• 着色剤
• 潤滑剤と滑剤
• その他
• 世界の医薬品添加剤市場、配合タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口製剤
• 局所用製剤
• 非経口製剤
• その他
• 世界の医薬品添加剤市場、無機化学品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 塩
• 酸化物
• ケイ酸塩
• 世界の医薬品添加剤市場、有機化学品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 糖類
• ポリマー
• 油脂
• 世界の医薬品添加剤市場、その他のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然賦形剤
• コーティング
• 抗酸化物質

第7章 地域別・国別分析

• 世界の医薬品添加剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の医薬品添加剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品添加剤市場：競合情勢
• 医薬品添加剤市場：企業プロファイル
  • BASF SE
  • Ashland Global Holdings
  • Evonik Industries AG
  • International Flavors & Fragrances, Inc
  • Roquette Freres

第31章 その他の大手企業と革新的企業

• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International Plc
• Kerry Group
• DuPont de Nemours, Inc.
• Sun Pharmaceuticals Industries Ltd
• Cipla Ltd
• Amster Microcell Private Limited
• Finar Limited
• P. D. Polychem Private Limited
• CAD Pharma Inc
• Maas Pharma Chemicals
• Aeon Procare Private Limited
• CSPC Pharmaceutical Group Ltd
• Allen & Hanburys Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 医薬品添加剤市場、2029年：新たな機会を提供する国
• 医薬品添加剤市場、2029年：新たな機会を提供するセグメント
• 医薬品添加剤市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Pharmaceutical excipients are non-active pharmaceutical ingredients (API) that form part of a drug delivery system and have undergone rigorous safety evaluations. While not possessing inherent activity, these excipients play a crucial role in facilitating the administration of the drug in the correct form and supporting its mode and site of action.

Pharmaceutical excipients come in various types, with the primary categories being inorganic chemicals, organic chemicals, and others. The pharmaceutical inorganic chemical sector focuses on the manufacturing, physical or chemical characteristics, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. These excipients serve different functionalities, including but not limited to fillers and diluents, suspending and viscosity agents, coating agents, flavoring agents, sweeteners, disintegrants, colorants, lubricants, glidants, and others. Additionally, they are utilized in diverse formulations such as oral, topical, and parental formulations.

The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical excipients market size has grown strongly in recent years. It will grow from $10257.72 billion in 2024 to $10926.17 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to strong economic growth in emerging markets, a surge in the sale of generic drugs and rising advanced healthcare infrastructure.

The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $14263.02 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to government initiatives, an increasing development of novel drugs, rising healthcare expenditure and a rapid growth in the elderly population will drive market growth. Major trends in the forecast period include focusing on sustainable packaging to reduce the use of plastics, focusing on mergers and acquisitions to strengthen market position, focusing on reducing greenhouse gas emissions and leveraging artificial intelligence to track nutrients, water levels and improve transparency in supply chains.

The global upswing in generic drug sales has played a pivotal role in the expansion of the pharmaceutical excipients market. Generic drugs serve as alternatives to branded medications, maintaining the same dosage form, safety, strength, route of administration, and quality. India, as noted by the India Brand Equity Foundation (IBEF), stands out as the largest contributor to generic medicines globally, with its generic drugs constituting 20% of the total global exports in this category. Notably, Indian pharmaceutical companies secured 300 approvals for generic drugs in the USA, further fueling the pharmaceutical excipients market due to increased demand for generic drugs.

The increasing sales of biologics are anticipated to drive growth in the pharmaceutical sterility testing market in the coming years. Biologics, or biological products, refer to medicines derived from living organisms and encompass a range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are employed in biologics to enhance stability, improve formulation, and ensure optimal delivery of active biological agents. For example, a report from the European Pharmaceutical Review in May 2022 projected that biologics sales will significantly exceed those of innovative small molecules over the next five years, with biologics expected to generate an additional $120 billion in sales by 2027. As a result, the rise in biologics sales is contributing to the growth of the pharmaceutical excipients market.

Major companies in the pharmaceutical excipient market are developing advanced excipients, such as high-purity excipients, to improve drug formulation stability, enhance bioavailability, and facilitate complex drug delivery systems. High-purity excipients are pharmaceutical excipients that have undergone advanced purification processes to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical company based in Switzerland, introduced three new VitiPure excipients aimed at enhancing the stability and solubility of active pharmaceutical ingredients (APIs). These products include VitiPure O 80 Superior, a high-purity polysorbate 80, VitiPure CO 35 Superior, a polyoxyl 35 castor oil, and VitiPure Meglumine LEX, a solubilizer with low bioburden. Designed for various drug delivery applications, particularly for sensitive formulations like mRNA vaccines and biologics, these excipients respond to the increasing demand for high-purity ingredients while complying with stringent regulatory standards.

Key players in the pharmaceutical excipient market are introducing advanced excipients such as Apisolex to streamline manufacturing processes and minimize losses of active pharmaceutical ingredients (APIs). Apisolex, an innovative solubility-enhancing excipient technology, addresses and overcomes solubility challenges. In a notable example from March 2022, Lubrizol Life Science (LLS) Health, a pharmaceutical contract development and drug product manufacturing organization based in the US, launched Apisolex to enhance solubility and simplify the manufacturing of parenteral drug products. This excipient can significantly increase solubility, support high drug loading, and optimize manufacturing by reducing API loss and ensuring efficient encapsulation.

In March 2024, Roquette, a France-based manufacturer of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for $2.85 billion. This acquisition positions Roquette as a preferred partner in the pharmaceutical industry, with the goal of addressing evolving customer needs and enhancing patient outcomes through improved treatment options. IFF Pharma Solutions is a US-based company that specializes in producing pharmaceutical excipients and specialty solutions for the pharmaceutical sector.

Major companies operating in the pharmaceutical excipients market include BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc, Roquette Freres, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Actelion Pharmaceuticals UK Ltd, Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma

North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
• 2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
• 3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
• Subsegments:
• 1) By Inorganic Chemicals: Salts; Oxides; Silicates
• 2) By Organic Chemicals: Sugars; Polymers; Oils And Fats
• 3) By Other Products: Natural Excipients; Coatings; Antioxidants
• Companies Mentioned: BASF SE; Ashland Global Holdings; Evonik Industries AG; International Flavors & Fragrances, Inc; Roquette Freres
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Excipients Market Characteristics

3. Pharmaceutical Excipients Market Trends And Strategies

4. Pharmaceutical Excipients Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pharmaceutical Excipients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Excipients Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Excipients Total Addressable Market (TAM)

6. Pharmaceutical Excipients Market Segmentation

• 6.1. Global Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inorganic Chemicals
• Organic Chemicals
• Other Products
• 6.2. Global Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fillers And Diluents
• Suspending And Viscosity Agents
• Coating Agents
• Binders
• Flavoring Agents And Sweeteners
• Disintegrants
• Colorants
• Lubricants And Glidants
• Other Functionalities
• 6.3. Global Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Formulation
• Topical Formulation
• Parenteral Formulation
• Other Formulations
• 6.4. Global Pharmaceutical Excipients Market, Sub-Segmentation Of Inorganic Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Salts
• Oxides
• Silicates
• 6.5. Global Pharmaceutical Excipients Market, Sub-Segmentation Of Organic Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sugars
• Polymers
• Oils And Fats
• 6.6. Global Pharmaceutical Excipients Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Excipients
• Coatings
• Antioxidants

7. Pharmaceutical Excipients Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Excipients Market

• 8.1. Asia-Pacific Pharmaceutical Excipients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Excipients Market

• 9.1. China Pharmaceutical Excipients Market Overview
• 9.2. China Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Excipients Market

• 10.1. India Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Excipients Market

• 11.1. Japan Pharmaceutical Excipients Market Overview
• 11.2. Japan Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Excipients Market

• 12.1. Australia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Excipients Market

• 13.1. Indonesia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Excipients Market

• 14.1. South Korea Pharmaceutical Excipients Market Overview
• 14.2. South Korea Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Excipients Market

• 15.1. Western Europe Pharmaceutical Excipients Market Overview
• 15.2. Western Europe Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Excipients Market

• 16.1. UK Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Excipients Market

• 17.1. Germany Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Excipients Market

• 18.1. France Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Excipients Market

• 19.1. Italy Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Excipients Market

• 20.1. Spain Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Excipients Market

• 21.1. Eastern Europe Pharmaceutical Excipients Market Overview
• 21.2. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Excipients Market

• 22.1. Russia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Excipients Market

• 23.1. North America Pharmaceutical Excipients Market Overview
• 23.2. North America Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Excipients Market

• 24.1. USA Pharmaceutical Excipients Market Overview
• 24.2. USA Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Excipients Market

• 25.1. Canada Pharmaceutical Excipients Market Overview
• 25.2. Canada Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Excipients Market

• 26.1. South America Pharmaceutical Excipients Market Overview
• 26.2. South America Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Excipients Market

• 27.1. Brazil Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Excipients Market

• 28.1. Middle East Pharmaceutical Excipients Market Overview
• 28.2. Middle East Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Excipients Market

• 29.1. Africa Pharmaceutical Excipients Market Overview
• 29.2. Africa Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Excipients Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Excipients Market Competitive Landscape
• 30.2. Pharmaceutical Excipients Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Ashland Global Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. International Flavors & Fragrances, Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roquette Freres Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Excipients Market Other Major And Innovative Companies

• 31.1. Archer Daniels Midland Company
• 31.2. Lubrizol Corporation
• 31.3. Croda International Plc
• 31.4. Kerry Group
• 31.5. DuPont de Nemours, Inc.
• 31.6. Sun Pharmaceuticals Industries Ltd
• 31.7. Cipla Ltd
• 31.8. Amster Microcell Private Limited
• 31.9. Finar Limited
• 31.10. P. D. Polychem Private Limited
• 31.11. CAD Pharma Inc
• 31.12. Maas Pharma Chemicals
• 31.13. Aeon Procare Private Limited
• 31.14. CSPC Pharmaceutical Group Ltd
• 31.15. Allen & Hanburys Ltd

32. Global Pharmaceutical Excipients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Excipients Market

34. Recent Developments In The Pharmaceutical Excipients Market

35. Pharmaceutical Excipients Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Excipients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Excipients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Excipients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer